Predicting drug clearance from recombinantly expressed CYPs: intersystem extrapolation factors
- 1 February 2004
- journal article
- research article
- Published by Taylor & Francis in Xenobiotica
- Vol. 34 (2) , 151-178
- https://doi.org/10.1080/00498250310001646353
Abstract
1. Recombinantly expressed human cytochromes P450 (rhCYPs) have been underused for the prediction of human drug clearance (CL). 2. Differences in intrinsic activity (per unit CYP) between rhCYP and human liver enzymes complicate the issue and these discrepancies have not been investigated systematically. We define intersystem extrapolation factors (ISEFs) that allow the use of rhCYP data for the in vitro–in vivo extrapolation of human drug CL and the variance that is associated with interindividual variation of CYP abundance due to genetic and environmental effects. 3. A large database (n = 451) of metabolic stability data has been compiled and used to derive ISEFs for the most commonly used expression systems and CYP enzymes. 4. Statistical models were constructed for the ISEFs to determine major covariates in order to optimize experimental design to increase prediction accuracy. 5. Suggestions have been made for the conduct of future studies using rhCYP to predict human drug clearance.Keywords
This publication has 69 references indexed in Scilit:
- Evaluation of SupermixTM as an in vitro model of human liver microsomal drug metabolismBiopharmaceutics & Drug Disposition, 2002
- CYP2D6.10 present in human liver microsomes shows low catalytic activity and thermal stabilityBiochemical and Biophysical Research Communications, 2002
- Prediction of Hepatic Metabolic ClearanceClinical Pharmacokinetics, 2001
- Diclofenac and Its Derivatives As Tools for Studying Human Cytochromes P450 Active Sites: Particular Efficiency and Regioselectivity of P450 2CsBiochemistry, 1999
- Prediction of Hepatic Metabolic Clearance Based on Interspecies Allometric Scaling Techniques and In Vitro-In Vivo CorrelationsClinical Pharmacokinetics, 1999
- Relative Quantities of Catalytically Active CYP 2C9 and 2C19 in Human Liver Microsomes: Application of the Relative Activity Factor ApproachJournal of Pharmaceutical Sciences, 1998
- Kinetic Characterization and Identification of the Enzymes Responsible for the Hepatic Biotransformation of Adinazolam and N-Desmethyladinazolam in ManJournal of Pharmacy and Pharmacology, 1998
- Interlaboratory comparison of the assessment of P450 activities in human hepatic microsomal samplesXenobiotica, 1998
- Lauric acid as a model substrate for the simultaneous determination of cytochrome P450 2E1 and 4A in hepatic microsomesChemical Research in Toxicology, 1994
- Cytochrome P450TB (CYP2C): A major monooxygenase catalyzing diclofenac 4′-hydroxylation in human liverLife Sciences, 1993